Rapid Micro Biosystems, Inc.
RPID- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001380106
No open-market purchases or sales by Rapid Micro Biosystems, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $30.3M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Rapid Micro Biosystems, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- +1 vs. Q1 2025
- Shares held
- 15.1M
- −169.5K (−1.1%) vs. Q1 2025
- Total value
- $52.3M
- +$11.8M (+29.2%) vs. Q1 2025
- New holders
- 3
- 11 more added
- Sold out
- 2
- 8 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RPID on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 34 | $30.3M |
| Q1 2026 | 46 | $36.0M |
| Q4 2025 | 42 | $42.5M |
| Q3 2025 | 29 | $49.5M |
| Q2 2025 | 29 | $52.3M |
| Q1 2025 | 28 | $40.4M |
| Q4 2024 | 19 | $10.8M |
| Q3 2024 | 19 | $15.6M |
| Q2 2024 | 21 | $12.2M |
| Q1 2024 | 23 | $18.2M |
| Q4 2023 | 26 | $14.9M |
| Q3 2023 | 23 | $23.2M |
| Q2 2023 | 24 | $21.9M |
| Q1 2023 | 31 | $29.9M |
| Q4 2022 | 42 | $27.7M |
| Q3 2022 | 53 | $82.8M |
| Q2 2022 | 52 | $112.2M |
| Q1 2022 | 59 | $181.0M |
| Q4 2021 | 55 | $227.9M |
| Q3 2021 | 49 | $401.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Rapid Micro Biosystems, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 15 | $52 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 100 | $345 | 0.00% | +100 | New |
| JPMorgan Chase & Co | 109 | $376 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 177 | $611 | 0.00% | +29+19.6% | Added |
| Advisor Group Holdings, Inc. | 300 | $1.03K | 0.00% | −300−50.0% | Reduced |
| Resources Management Corp | 500 | $2.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 8,693 | $30.0K | 0.00% | +8,672+41,295.2% | Added |
| Legato Capital Management LLC | 14,684 | $50.7K | 0.01% | −731−4.7% | Reduced |
| American Century Companies Inc | 16,922 | $58.4K | 0.00% | +5,341+46.1% | Added |
| Mariner, LLC | 20,225 | $69.8K | 0.00% | −11,706−36.7% | Reduced |
| Citadel Advisors LLC | 20,762 | $71.6K | 0.00% | +20,762 | New |
| Morgan Stanley | 36,223 | $125.0K | 0.00% | +16,658+85.1% | Added |
| Dimensional Fund Advisors LP | 40,387 | $139.7K | 0.00% | +19,220+90.8% | Added |
| XTX Topco Ltd | 41,800 | $144.2K | 0.01% | +41,800 | New |
| Evernest Financial Advisors, LLC | 44,000 | $151.8K | 0.05% | −87,265−66.5% | Reduced |
| Northern Trust Corp | 48,559 | $167.5K | 0.00% | +2,915+6.4% | Added |
| Susquehanna International Group, LLP | 51,859 | $178.9K | 0.00% | −106,683−67.3% | Reduced |
| State Street Corp | 59,874 | $206.6K | 0.00% | 00.0% | Unchanged |
| Essex Investment Management Co LLC | 62,326 | $215.0K | 0.04% | −731−1.2% | Reduced |
| Renaissance Technologies LLC | 110,987 | $382.9K | 0.00% | +400+0.4% | Added |
| EAM Investors, LLC | 170,105 | $586.9K | 0.09% | −6,844−3.9% | Reduced |
| Geode Capital Management, LLC | 204,079 | $704.3K | 0.00% | +3,143+1.6% | Added |
| BlackRock, Inc. | 476,817 | $1.65M | 0.00% | −165,284−25.7% | Reduced |
| Advent International Corp | 577,777 | $1.99M | 0.06% | 00.0% | Unchanged |
| Vanguard Group Inc | 904,363 | $3.12M | 0.00% | +14,085+1.6% | Added |
| Parkman Healthcare Partners LLC | 913,443 | $3.15M | 0.36% | +177,822+24.2% | Added |
| Schonfeld Strategic Advisors LLC | 1,037,668 | $3.58M | 0.03% | +8,863+0.9% | Added |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 1,848,296 | $6.38M | 23.83% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 8,434,560 | $29.1M | 3.64% | 00.0% | Unchanged |
| Omers Administration Corp | 0 | $0 | 0.00% | −109,400−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −350−100.0% | Sold out |